Medicine and Dentistry
Soft Tissue Sarcoma
100%
Neoplasm
95%
Nodular Melanoma
91%
Cytoreductive Surgery
82%
Surgery
76%
Peritoneum Metastasis
63%
Hyperthermic Intraperitoneal Chemotherapy
62%
Radiation Therapy
48%
Limb Perfusion
47%
Retroperitoneal Lymph Node Dissection
44%
Quality of Life
40%
Recurrent Disease
39%
Sentinel Node
35%
Sarcoma
35%
Disease
27%
Laparoscopy
27%
Positron Emission Tomography
27%
Diagnosis
25%
Overall Survival
25%
Limb Salvage
24%
Peritoneum Cancer
22%
Systemic Therapy
20%
Fluorine-18
19%
Limb
19%
Amputation
19%
Sentinel Lymph Node
19%
Colorectal Cancer
18%
Retrospective Cohort Study
18%
Radioactive Tracer
17%
Local Therapy
17%
Positron Emission Tomography-Computed Tomography
17%
Tissue Injury
16%
External Beam Radiotherapy
16%
Merkel Cell Carcinoma
16%
Systematic Review
16%
Wound Complication
16%
Bevacizumab
15%
Adjuvant Therapy
14%
Postoperative Complication
14%
Clinical Trial
13%
Surgeon
12%
Patient Referral
12%
Computer Assisted Tomography
11%
Laparotomy
11%
Positron Emission Tomography
11%
Fluorodeoxyglucose
11%
Metastatic Carcinoma
10%
Osteosarcoma
10%
Venous Ulcer
10%
Patient-Reported Outcome
10%
Keyphrases
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
69%
Colorectal Peritoneal Metastases
52%
Cytoreductive Surgery
43%
Soft Tissue Sarcoma
41%
Extremity Soft Tissue Sarcoma
27%
Diagnostic Laparoscopy
25%
Peritoneal Cancer Index
21%
Netherlands
18%
Neoadjuvant
18%
Computed Tomography
17%
Retrospective Cohort Study
16%
Health Care Costs
16%
Stage III Melanoma
16%
Selection Tool
16%
Hyperthermic Isolated Limb Perfusion
12%
Histological Response
12%
Treatment-related
11%
Survival Outcomes
11%
Peritoneal Metastasis
10%
Sarcoma Treatment
10%
Bone Sarcoma
10%
Overall Survival
10%
Advanced Melanoma
10%
Melanoma
10%
European Organizations
10%
Tumor Patients
9%
Cancer Treatment
9%
Tumor Response
9%
Population-based Study
9%
Chemotherapy
9%
Resection
9%
Exploratory Laparotomy
9%
Retrospective Observational Study
9%
External Beam Radiotherapy
9%
Health-related Quality of Life
8%
Surgeons
8%
Systemic Therapy
8%
Deep-seated
8%
Patients with Colorectal Cancer
8%
Beta-catenin
8%
Older Adults
8%
Guided Visualization
8%
Metastatic GIST
8%
Patients with Breast Cancer
8%
Volume-of-interest
8%
Preoperative Systemic Therapy
8%
Positron Emission Tomography
8%
Therapeutic Intervention
8%
AJCC Stage
8%
Lymph Node Positive
8%